CN103598590B - Traditional Chinese medicine composition for decreasing blood sugar and application thereof - Google Patents
Traditional Chinese medicine composition for decreasing blood sugar and application thereof Download PDFInfo
- Publication number
- CN103598590B CN103598590B CN201310606824.9A CN201310606824A CN103598590B CN 103598590 B CN103598590 B CN 103598590B CN 201310606824 A CN201310606824 A CN 201310606824A CN 103598590 B CN103598590 B CN 103598590B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- root
- sealwort
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 67
- 239000000203 mixture Substances 0.000 title claims abstract description 47
- 239000008280 blood Substances 0.000 title abstract description 10
- 210000004369 blood Anatomy 0.000 title abstract description 10
- 235000000346 sugar Nutrition 0.000 title abstract description 5
- 230000003247 decreasing effect Effects 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 claims abstract description 25
- 238000000227 grinding Methods 0.000 claims abstract description 18
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 38
- 239000002775 capsule Substances 0.000 claims description 34
- 239000009636 Huang Qi Substances 0.000 claims description 28
- 244000046146 Pueraria lobata Species 0.000 claims description 28
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 23
- 241000383295 Notholithocarpus densiflorus Species 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 10
- 239000012467 final product Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 238000009472 formulation Methods 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 239000012982 microporous membrane Substances 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 238000005238 degreasing Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 230000036541 health Effects 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 230000005855 radiation Effects 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 21
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 3
- 230000007423 decrease Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241001633106 Lithocarpus Species 0.000 abstract 1
- 241001121987 Scrophularia ningpoensis Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 description 15
- 238000000605 extraction Methods 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 238000010298 pulverizing process Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 235000008504 concentrate Nutrition 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical group Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- -1 flavouring Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000001970 hydrokinetic effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 229960004329 metformin hydrochloride Drugs 0.000 description 1
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin hydrochloride Natural products CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for decreasing blood sugar and application thereof. The composition comprises the following components in parts by weight: 5 to 10 parts of scrophularia ningpoensis, 10 to 24 parts of astragalus membranaceus, 30 to 38 parts of radix puerariae, 30 to 40 parts of rhizoma polygonati, and 10 to 25 parts of lithocarpus polystachyus leaves. The preparation method of the traditional Chinese medicine composition comprises the step of superfine grinding by which the effective ingredients can be quickly dissolved out and absorbed by a human body. The traditional Chinese medicine composition has the effects of assisting to decrease blood sugar, comprehensively regulating physical function, treating both symptoms and root causes, and consolidating the effect.
Description
Technical field
The invention belongs to Chinese medicine health-care technical field, be specifically related to one and fall hypoglycemic Chinese medicine composition and application thereof.
Background technology
Diabetes a kind ofly increase endocrine and metabolic disorders disease for feature with plasma glucose levels, be a kind ofly to interact with inherent cause and environmental factor, the multifactor disease jointly caused.Clinically, diabetes show typical three-many-one-little symptom, i.e. many drinks, diuresis, the symptom of eating more and losing weight, and the various complication caused by it have become that patient is disabled, lethal one of the main reasons.This disease is difficult to cure, needs of patients Long-term taking medicine, maintains blood sugar in normal range (NR) or stop blood sugar to raise further, delay increasing the weight of and the generation of complication of the state of an illness by medicine.
At present, the treatment of diabetes is main mainly with Western medicine, as sulfonylureas and biguanides, although hypoglycemic effect is rapid, act on single, increase pancreas islet burden, and there is the side effect such as hypoglycemia, gastrointestinal reaction, along with the prolongation for the treatment of time, hypoglycemic effect is reduction trend, and long-term taking also can cause liver kidney toxic and side effect.
Theory of traditional Chinese medical science thinks that diabetes spp is in category of quenching one's thirst, its interpretation of the cause, onset and process of an illness be mainly lung, stomach, the dirty the moon of kidney three thanks to scorching, calcination body fluid, disappear caused by bright water paddy.Chinese traditional herbs treatment diabetes action temperature and lasting, side effect is little, and the mechanism of action has Mutiple Targets, manifold effect, multi-functional Comprehensive Characteristics.
If filter out from Chinese medicine effectively, the hypoglycemic medicinal material of safety and par, be made into the formulation conveniently taken, take while other medicines treatment diabetes, can play assistant hypoglycemic, comprehensively regulating physical function, treats both principal and secondary aspect of disease, the effect of consolidate curative effect.
Summary of the invention
In view of this, the object of the present invention is to provide one to fall hypoglycemic Chinese medicine composition, said composition can play assistant hypoglycemic, comprehensively regulating physical function, treats both principal and secondary aspect of disease, the effect of consolidate curative effect.
For solving the problems of the technologies described above, the technical solution used in the present invention is:
Of the present inventionly fall hypoglycemic Chinese medicine composition, comprise the component of following weight proportion: radix scrophulariae 5 ~ 10 parts, the Radix Astragali 10 ~ 24 parts, the root of kudzu vine 30 ~ 38 parts, sealwort 30 ~ 40 parts, manyspike tanoak leaf 10 ~ 25 parts.
Further, of the present inventionly fall hypoglycemic Chinese medicine composition, preferably include the component of following weight proportion: radix scrophulariae 6 ~ 7 parts, the Radix Astragali 13 ~ 17 parts, the root of kudzu vine 32 ~ 36 parts, sealwort 34 ~ 36 parts, manyspike tanoak leaf 20 ~ 24 parts.Describedly fall hypoglycemic Chinese medicine composition, more preferably comprise the component of following weight proportion: radix scrophulariae 7 parts, the Radix Astragali 17 parts, the root of kudzu vine 32 parts, sealwort 34 parts, manyspike tanoak leaf 24 parts.
Above-mentioned composition is in a particular application, different depending on concrete dosage form, also can add filler, cosolvent, flavouring, bacteriostatic agent etc.
According to " Chinese medicine voluminous dictionary " (Nanjing University of Traditional Chinese Medicine writes, Shanghai science tech publishing house, the second edition), the mechanism of described five tastes raw medicinal material is as follows: radix scrophulariae, return lung, stomach, kidney channel, there is cool blood, nourishing Yin and falling fire, effect of removing toxic substances, warm heat disease heat can be treated and enter ying blood, body heat, polydipsia, tongue is deep red, and send out spot, hectic fever due to yin labor is coughed, dysphoria is insomnia, and constipation is hindered in Tianjin, and order is puckery dim-sighted, abscess of throat, scrofula subcutaneous nodule, skin sore etc.The Radix Astragali, returns lung, the spleen channel, has invigorating qi for strengthening superficies, diuresis holder poison, apocenosis, and expelling pus and promoting granulation is weak for the deficiency of vital energy, anorexia and loose stool, and the sinking of qi of middle-jiao, rushes down prolapse of the anus for a long time, uterine bleeding of having blood in stool, exterior deficiency spontaneous perspiration, deficiency of vital energy oedema, and ulcer difficulty is burst, and burst for a long time and do not hold back, flaccidity of limbs due to deficiency of blood is yellow, and interior heat is quenched one's thirst; Chronic rephrilis protinuria, diabetes.Sealwort, returns spleen, stomach warp, has Yin nourishing and lung moistening, invigorate the spleen and benefit qi, effect of Zishen fill fine, can treat deficiency of Yin labor and cough, xeropulmonary cough; Insufficiency of the spleen weak, the few dry of food, quenches one's thirst; Deficiency of the kidney soreness and weakness of waist and knees, impotence and seminal emission, tinnitus order is dark, poliosis, and body void is won thin, wind favus disease etc.The root of kudzu vine, returns spleen, stomach warp, has expelling pathogenic factors from muscles and skin and deliver, promote the production of body fluid to quench thirst, rise effect of positive antidiarrheal, cure mainly fever caused by exogenous pathogens, rigid and painful head and neck, and measles goes out smooth from the beginning of, rash, warm disease is thirsty, diabete, has loose bowels, dysentery etc.Manyspike tanoak leaf, has clearing heat and detoxicating, reduces phlegm, dispel the wind, step-down, main damp-heat dysentery, cough with lung heat, ulcer sores, pruitus, hypertension.
Described gomi herbs weight proportion in the composition, with the prepared slices of Chinese crude drugs through concocting for benchmark.Said composition, when embody rule, can adopt traditional decoction form, also can be used as functional materials and adds in health food, also can be prepared as the preparation being easy to preserve and take.Another order of the present invention is just that protection is of the present invention and falls hypoglycemic Chinese medicine composition and preparing the application in Chinese medicine preparation or health products.Particularly, the formulation of described preparation is pill, powder, tablet, capsule, granule, paste, oral liquid etc.
There is provided a kind of below the present invention and utilize the above-mentioned method of falling hypoglycemic Chinese medicine composition and preparing preparation, the method is conducive to the stripping of each medicinal material active ingredient in composition, and extraction efficiency is high, and the concentrate of preparation is also convenient to further preparation.
For solving the problems of the technologies described above, the technical solution used in the present invention is:
Fall the method that hypoglycemic Chinese medicine composition prepares preparation, comprise the following steps:
A, get the prepared slices of Chinese crude drugs respectively ultramicro grinding of manyspike tanoak leaf, radix scrophulariae, the Radix Astragali, the root of kudzu vine and sealwort, obtain medicinal powder;
B, by the above-mentioned weight proportion falling hypoglycemic Chinese medicine composition, the medicinal powder getting steps A carries out ultrasonic wave or microwave radiation exaraction, obtains extract;
C, the extract getting step B carry out filtering with microporous membrane, concentrated, obtain concentrate for preparation and get final product.
Further, the preparation method of the prepared slices of Chinese crude drugs of described radix scrophulariae, the Radix Astragali, the root of kudzu vine and sealwort comprises the following steps: the fresh medicinal material getting radix scrophulariae, the Radix Astragali, the root of kudzu vine and sealwort, through cleaning, drying, stripping and slicing, after degreasing, dries obtained.
Further, described steps A is by medicine materical crude slice ultramicro grinding to 200 order or thinner.
Ultramicro grinding described in steps A refers to that utilizing machinery or hydrokinetic method to overcome solid interior cohesiveness makes it broken, material particles more than millimeter can be crushed to the operating technology of micron, the powder obtained thus has good dissolubility, dispersiveness, adsorptivity, chemical reactivity etc.Superfine communication technique is used for the present invention, thus obtained drug powder, being directly used in preparation has good formulation properties, and for further extraction, extracted amount and the extraction efficiency of its active component also increase.
In above-mentioned preparation method, extract again after ultramicro grinding, can extraction efficiency be improved, increase the stripping of active component; And when preparing the prepared slices of Chinese crude drugs, ungrease treatment is carried out to medicinal material, be then conducive to the carrying out of ultramicro grinding.During concrete crushing operation, after can first tentatively pulverizing with common grinder, then be crushed to required granularity with micronizer.
It is the special roles such as the cavitation utilizing ultrasonic wave to produce that ultrasonic wave described in step B extracts, one that chemical composition contained in medicine is extracted quickly and efficiently new extractive technique.Its operating process is: add in a reservoir and extract solvent (water, ethanol or other organic solvents etc.), Chinese medicine is pulverized or is cut into graininess as required, puts into and extracts solvent; The bonding transducer oscillator of outer wall of container or oscillator is sealed in stainless steel box drops in container; Open supersonic generator, oscillator sends ultrasonic wave in extraction solvent, ultrasonic wave extract in solvent ' cavitation effect ' that produce and mechanism one side can the cell membrane of broken medicinal material effectively, make active ingredient be free state and dissolve in extract in solvent, the molecular motion of extracting solvent can be accelerated on the other hand, make to extract the active ingredient Rapid contact in solvent and medicinal material, mutually fused, mixing.Ultrasonic wave extracts the extraction low with its Extracting temperature, recovery rate is high, extraction time is short unique advantage is widely used in Chinese medicine and various animal and plant effective content, is to substitute tradition to shear the modern high technology means that process realization is efficient, energy-saving and environmental protection formula is extracted.Described microwave auxiliary extraction (MAE), i.e. microwave abstracting, that the difference absorbing microwave ability according to different material makes some component in some region of base matter or extraction system by selective heating, thus make to be extracted material and be separated from matrix or system, enter into that dielectric constant is less, the extractant of microwave absorption capacity relative mistake, reach the object of extraction.The present invention adopts ultrasonic wave or microwave radiation exaraction, due to the advantage of the method itself, and the synergy of the present composition in leaching process, recovery rate and extraction efficiency can be significantly improved.
Filtering with microporous membrane described in step C is also known as secondary filter, mainly for separating of submicron particles, current most widely used a kind of compartment analysis subparticle and ultra-clean degerming means, have simple to operate, floor space is little, without phase transformation and can not produce the advantages such as new polluter, good separating effect in processing procedure.In method of the present invention, after first can carrying out coarse filtration to extract, carry out filtering with microporous membrane again.
Extract after filtering concentrates by modes such as atmospheric evaporation, reduction vaporization, thin film evaporation.The concentrate obtained can carry out preparation according to the conventional method of Chinese medicine preparation, finally makes the various formulations such as pill, powder, tablet, capsule, granule.According to standby concrete formulation of drawing up, necessary diluent, adhesive, disintegrant, lubricant etc. can be added.
The present invention also have an object to be providing a kind of utilizes the above-mentioned method of falling hypoglycemic Chinese medicine composition and preparing capsule, the method operation is simple, product storage and take all very convenient.The technical scheme adopted is:
Fall the method that hypoglycemic Chinese medicine composition prepares capsule, comprise the following steps:
By the above-mentioned weight proportion falling hypoglycemic Chinese medicine composition, get the prepared slices of Chinese crude drugs ultramicro grinding of manyspike tanoak leaf, radix scrophulariae, the Radix Astragali, the root of kudzu vine and sealwort respectively, cross 200 mesh sieves, obtain medicinal powder batch mixing, encapsulated, to obtain final product.
Further, the preparation method of the prepared slices of Chinese crude drugs of described radix scrophulariae, the Radix Astragali, the root of kudzu vine and sealwort comprises the following steps: the fresh medicinal material getting radix scrophulariae, the Radix Astragali, the root of kudzu vine and sealwort, through cleaning, drying, stripping and slicing, after degreasing, dries obtained.
The ultramicro grinding medicinal powder granularity that said method obtains is suitable for, and has both been conducive to the absorption of human body, has had again good mobility, be convenient to pharmaceutical practice.As the further improvement of said method, preferably capsule is prepared into the capsule containing medicinal ingredient 0.3g/ grain.
Beneficial effect of the present invention: of the present inventionly fall hypoglycemic Chinese medicine composition, follows the principle of tcm syndrome differentiation and treatment, all medicine phases and, there is nourishing kidney-YIN, fall hypoglycemic effect, integration of drinking and medicinal herbs, cheap.The medicine for the treatment of diabetes by itself and other is taken simultaneously, and particularly as adjuvant drug or the health products of chemical classes antidiabetic drug, can play assistant hypoglycemic, comprehensively regulating physical function, treats both principal and secondary aspect of disease, the effect of consolidate curative effect; For having Diabetes family history or three high diabetes vulnerable crowds, it can be used as health products to take and can play the effect preventing diabetes.This falls hypoglycemic Chinese medicine composition can be prepared as multiple formulation, and its preparation method adopts superfine communication technique again, makes the product of acquisition have good dissolubility, dispersiveness, adsorptivity, chemical reactivity etc., is easy to follow-up pharmaceutical practice and absorption of human body.Especially the capsule prepared as stated above, operation is simple, and product is stored and taken all very convenient.
Detailed description of the invention
In order to make the object, technical solutions and advantages of the present invention clearly, below the preferred embodiments of the present invention and contrast experiment's example are described in detail.
Embodiment 1
Press row weight proportion and prepare each component: radix scrophulariae 10g, Radix Astragali 24g, root of kudzu vine 30g, sealwort 30g, manyspike tanoak leaf 25g.Each component is tentatively pulverized respectively, carries out ultramicro grinding again after pulverizing, and cross 200 mesh sieves, batch mixing, is pressed into 0.25g/ sheet, film coating, obtains final product.
Embodiment 2
Press row weight proportion and prepare each component: radix scrophulariae 6g, Radix Astragali 18g, root of kudzu vine 36g, sealwort 34g, manyspike tanoak leaf 23g.Each component is tentatively pulverized respectively, carries out ultramicro grinding again after pulverizing, and cross 200 mesh sieves, batch mixing, packing, sterilizing, obtains powder.
Embodiment 3
Press row weight proportion and prepare each component: radix scrophulariae 7g, Radix Astragali 14g, root of kudzu vine 36g, sealwort 36g, manyspike tanoak leaf 22g.Each component is tentatively pulverized respectively, carries out ultramicro grinding again after pulverizing, and cross 200 mesh sieves, batch mixing, encapsulated 0.3g/ grain, to obtain final product.
Embodiment 4
Press row weight proportion and prepare each component: radix scrophulariae 5g, Radix Astragali 13g, root of kudzu vine 38g, sealwort 40g, manyspike tanoak leaf 20g.Each component is tentatively pulverized respectively, carries out ultramicro grinding again after pulverizing, and cross 200 mesh sieves, batch mixing, encapsulated 0.3g/ grain, to obtain final product.
Embodiment 5
Press row weight proportion and prepare each component: radix scrophulariae 700g, Radix Astragali 1700g, root of kudzu vine 3200g, sealwort 3400g, manyspike tanoak leaf 2400g.Each component is tentatively pulverized respectively, carries out ultramicro grinding again after pulverizing, and cross 200 mesh sieves, batch mixing, encapsulated 0.3g/ grain, to obtain final product.
Embodiment 6
Press row weight proportion and prepare each component: radix scrophulariae 500g, Radix Astragali 1000g, root of kudzu vine 3000g, sealwort 3000g, manyspike tanoak leaf 1000g.Each component is tentatively pulverized respectively, carries out ultramicro grinding again after pulverizing, and cross 200 mesh sieves, add filler starch 2900g, batch mixing, encapsulated 0.3g/ grain, to obtain final product.
Embodiment 7
Get the fresh medicinal material of radix scrophulariae, the Radix Astragali, the root of kudzu vine and sealwort, through cleaning, drying, stripping and slicing, after degreasing, dry the obtained prepared slices of Chinese crude drugs.Get the prepared slices of Chinese crude drugs of manyspike tanoak leaf again, and the prepared slices of Chinese crude drugs of aforementioned obtained radix scrophulariae, the Radix Astragali, the root of kudzu vine and sealwort ultramicro grinding respectively, obtain medicinal powder.Press row weight proportion and take each medicinal powder: radix scrophulariae 10g, Radix Astragali 24g, root of kudzu vine 30g, sealwort 30g, manyspike tanoak leaf 25g, all medicinal powder is mixed, proceeding to model is in the ultrosonic extractor of SBL-ultrasonic wave (Ningbo Xin Zhi biotechnology Co., Ltd), add water 2000ml, ultrasonic power 600W, ultrasonic extraction 1 hour.After extraction completes, suction filtration obtains filtrate, then obtains filtrate with the filtering with microporous membrane of 0.45 μm.Filtrate evaporated under reduced pressure after filtering with microporous membrane is concentrated into 500ml, adds white granulated sugar 250g, and dissolve mixing, sterilizing, obtains the syrup of this Chinese medicine composition.
Contrast experiment's example 1
Accept out-patient 150 example for medical treatment, the wherein male sex 90 people, women 60 people, 50 years old mean age, is divided into A, B1, B2, C1, C2 five groups at random, often organizes 30 people: A group, as reference group, takes starch capsule 1,3 times/day; B1 and B2 group takes the capsule 1 of embodiment 5 and embodiment 6 preparation respectively, 3 times/day; C1 and C2 group takes the capsule 2 of embodiment 5 and embodiment 6 preparation respectively, 3 times/day.
All patients take capsule continuously and stop using after 30 days, then observe 20 days.Respectively take capsule first 1 day, take capsule after within the 30th day and after taking capsule the 50th day, carry out detection fasting blood-glucose index.The surveyed index average ± standard deviation of result represents, the statistical method of application t inspection is analyzed result, and P < 0.05 thinks tool significance.Test result is as follows:
Table 1 patient takes the test result of fasting blood-glucose before and after capsule (mmol/L)
| Group | Take capsule situation | Take first 1 day | Take latter 30th day | Take latter 50th day |
| A group | Starch capsule 1,3 times/day | 11.9±0.8 | 12.8±1.0 | 12.9±0.8 |
| B1 group | Embodiment 5 capsule 1,3 times/day | 12.0±1.1 | 8.6±1.0* | 9.6±1.4* |
| B2 group | Embodiment 6 capsule 1,3 times/day | 12.1±0.9 | 9.4±1.2* | 9.9±1.6* |
| C1 group | Embodiment 5 capsule 2,3 times/day | 12.2±1.3 | 8.7±1.1* | 9.8±1.5* |
| C2 group | Embodiment 6 capsule 2,3 times/day | 11.9±1.0 | 8.6±0.9* | 9.5±1.3* |
Note *: with take before compare: P < 0.05, its otherness has statistical significance.
As shown in Table 1, diabetes patient is when refusing to obey other hypoglycemic medicine, only take the present invention and fall capsule prepared by hypoglycemic Chinese medicine composition, all before taking capsule, obvious decline is had at the blood glucose test result of the 30th day and the 50th day, and after drug withdrawal the 50th day, still there is not remarkable bounce-back in blood glucose test result.In addition, from the data of B1 and B2, C1 and C2, take embodiment 6, according to capsule prepared by composition minority component, still there is the curative effect suitable with embodiment 5 capsule.Therefore, of the present invention to fall hypoglycemic Chinese medicine composition curative effect reliable, has and obviously fall hypoglycemic function, has prevention effect to the generation of diabetes and development.
Contrast experiment's example 2
Accept out-patient 60 example for medical treatment, the wherein male sex 34 people, women 26 people, 50 years old mean age, is divided into A, B two groups at random, often organizes 30 people: A, B group all takes metformin hydrochloride tablet, each 0.25g, 3 times/day; B group also takes capsule 1 prepared by embodiment 5 simultaneously, 3 times/day.
All patients take capsule continuously and stop using after 30 days, then observe 20 days.Respectively take capsule first 1 day, take capsule after within the 30th day and after taking capsule the 50th day, detect, Detection of content comprises fasting blood-glucose.The surveyed index mean ± standard deviation of result represents, the statistical method of application t inspection is analyzed result, and P < 0.05 thinks tool significance.Test result is as follows:
The contrast test result of fasting blood-glucose (mmol/L) after table 2 patient in combination medication
Compare before noting * and taking: P < 0.05, its otherness has statistical significance.
As shown in Table 2, diabetes patient, when taking other hypoglycemic medicine, also takes the present invention and falls capsule prepared by hypoglycemic Chinese medicine composition, hypoglycemic effect better, more stable.
What finally illustrate is, above embodiment is only in order to illustrate technical scheme of the present invention and unrestricted, although with reference to preferred embodiment to invention has been detailed description, those of ordinary skill in the art is to be understood that, can modify to technical scheme or equivalent replacement, and not departing from aim and the scope of technical solution of the present invention, it all should be encompassed in the middle of right of the present invention.
Claims (9)
1. fall hypoglycemic Chinese medicine composition, be made up of the component of following weight proportion: radix scrophulariae 5 ~ 10 parts, the Radix Astragali 10 ~ 24 parts, the root of kudzu vine 30 ~ 38 parts, sealwort 30 ~ 40 parts, manyspike tanoak leaf 10 ~ 25 parts.
2. according to claim 1ly fall hypoglycemic Chinese medicine composition, it is characterized in that: be made up of the component of following weight proportion: radix scrophulariae 6 ~ 7 parts, the Radix Astragali 13 ~ 17 parts, the root of kudzu vine 32 ~ 36 parts, sealwort 34 ~ 36 parts, manyspike tanoak leaf 20 ~ 24 parts.
3. according to claim 1ly fall hypoglycemic Chinese medicine composition, it is characterized in that: be made up of the component of following weight proportion: radix scrophulariae 7 parts, the Radix Astragali 17 parts, the root of kudzu vine 32 parts, sealwort 34 parts, manyspike tanoak leaf 24 parts.
4. the hypoglycemic Chinese medicine composition that falls described in any one of claims 1 to 3 is preparing the application in Chinese medicine preparation or health products.
5. application according to claim 4, is characterized in that: the formulation of described preparation is pill, powder, tablet, capsule or granule.
6. utilize and fall the method that hypoglycemic Chinese medicine composition prepares preparation described in any one of claim 1 to 3, comprise the following steps:
A, get the prepared slices of Chinese crude drugs respectively ultramicro grinding of manyspike tanoak leaf, radix scrophulariae, the Radix Astragali, the root of kudzu vine and sealwort, obtain medicinal powder;
B, by weight proportion described in any one of claims 1 to 3, the medicinal powder getting steps A carries out ultrasonic wave or microwave radiation exaraction, obtains extract;
C, the extract getting step B carry out filtering with microporous membrane, concentrated, obtain concentrate for preparation and get final product;
Described steps A is by medicine materical crude slice ultramicro grinding to 200 order or thinner.
7. the method for falling hypoglycemic Chinese medicine composition and preparing preparation according to claim 6, it is characterized in that: the preparation method of the prepared slices of Chinese crude drugs of described radix scrophulariae, the Radix Astragali, the root of kudzu vine and sealwort comprises the following steps: the fresh medicinal material getting radix scrophulariae, the Radix Astragali, the root of kudzu vine and sealwort, through cleaning, drying, stripping and slicing, after degreasing, dry obtained.
8. utilize and fall the method that hypoglycemic Chinese medicine composition prepares capsule described in any one of claim 1 to 3, comprise the following steps:
Get the prepared slices of Chinese crude drugs ultramicro grinding of manyspike tanoak leaf, radix scrophulariae, the Radix Astragali, the root of kudzu vine and sealwort by weight proportion described in any one of claims 1 to 3 respectively, cross 200 mesh sieves, obtain medicinal powder batch mixing, encapsulated, to obtain final product.
9. the method for falling hypoglycemic Chinese medicine composition and preparing capsule according to claim 8, it is characterized in that: the preparation method of the prepared slices of Chinese crude drugs of described radix scrophulariae, the Radix Astragali, the root of kudzu vine and sealwort comprises the following steps: the fresh medicinal material getting radix scrophulariae, the Radix Astragali, the root of kudzu vine and sealwort, through cleaning, drying, stripping and slicing, after degreasing, dry obtained.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310606824.9A CN103598590B (en) | 2013-11-25 | 2013-11-25 | Traditional Chinese medicine composition for decreasing blood sugar and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310606824.9A CN103598590B (en) | 2013-11-25 | 2013-11-25 | Traditional Chinese medicine composition for decreasing blood sugar and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103598590A CN103598590A (en) | 2014-02-26 |
| CN103598590B true CN103598590B (en) | 2015-05-20 |
Family
ID=50116904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310606824.9A Active CN103598590B (en) | 2013-11-25 | 2013-11-25 | Traditional Chinese medicine composition for decreasing blood sugar and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103598590B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106432261A (en) * | 2016-09-23 | 2017-02-22 | 湛江嘉诚科技服务有限公司 | Technology for drying monascus yellow pigment through spray dryer |
| CN107087789A (en) * | 2017-06-02 | 2017-08-25 | 重庆市中药研究院 | A kind of yellow hypoglycemic Ultramicro-powder pharmaceutical formulation of mulberry Pueraria lobota and its application |
| CN108771112A (en) * | 2018-05-17 | 2018-11-09 | 哈尔滨医科大学 | Multiple-ear rock Ke's compound rice flour and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102144692A (en) * | 2010-09-25 | 2011-08-10 | 重庆辰龙制药有限公司 | Sweet tea and preparation method thereof |
| CN102218085A (en) * | 2010-04-13 | 2011-10-19 | 常州善美药物研究开发中心有限公司 | Quality control method for leaves of lithocarpus litseifolius(Hance)Chun as medicinal material |
| CN102526484A (en) * | 2012-02-16 | 2012-07-04 | 许从玉 | Medicinal composition for decreasing blood sugar |
-
2013
- 2013-11-25 CN CN201310606824.9A patent/CN103598590B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102218085A (en) * | 2010-04-13 | 2011-10-19 | 常州善美药物研究开发中心有限公司 | Quality control method for leaves of lithocarpus litseifolius(Hance)Chun as medicinal material |
| CN102144692A (en) * | 2010-09-25 | 2011-08-10 | 重庆辰龙制药有限公司 | Sweet tea and preparation method thereof |
| CN102526484A (en) * | 2012-02-16 | 2012-07-04 | 许从玉 | Medicinal composition for decreasing blood sugar |
Non-Patent Citations (5)
| Title |
|---|
| 中药治疗糖尿病的心得体会;李春亮等;《张家口医学院学报》;20021231;第19卷(第03期);14-15 * |
| 浅谈影响中药提取质量的主要因素;鲁冰;《山东中医杂志》;20031031;第22卷(第10期);627-628 * |
| 糖尿病从脾论治浅析;张育清;《实用中医内科杂志》;20050430;第19卷(第02期);124 * |
| 糖尿病药对临床应用心得;李凤鸣;《中国社区医师(综合版)》;20071231;第9卷(第13期);147-148 * |
| 赵艳华.糖尿病的临床中药治疗体会.《中国保健(医学研究版)》.2007,第15卷(第14期),116-117. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103598590A (en) | 2014-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100353983C (en) | Chinese medicine preparation for reducing sugar | |
| CN103947890B (en) | A kind of feed, Chinese medicine composition and preparation method for preventing and treating el pato's parasitosis | |
| CN105147618A (en) | Preparation method for Chinese herb decocting-free preparation containing heat-sensitive effective components | |
| CN103598590B (en) | Traditional Chinese medicine composition for decreasing blood sugar and application thereof | |
| CN104523862A (en) | Highly-concentrated rheum officinale formula granules with purgation effect and preparation method thereof | |
| CN101485870A (en) | Medicament for promoting digestion and expelling intestinal parasites | |
| CN101085039A (en) | Composition for preventing and treating diabetes (hyperglycaemia) and its preparation method | |
| CN106362004A (en) | Compound fresh dendrobium nobile granules and preparation method thereof | |
| CN102824480A (en) | Auxiliary blood sugar decreasing composite containing tibetan medicine edgeworthia gardneri and preparation method of composite | |
| CN102805818B (en) | Hypoglycemic drug and preparation method thereof | |
| CN108143833A (en) | A kind of preparation method of licorice piece | |
| CN105168140A (en) | Preparation method and an application of non-decocting preparation of fresh traditional Chinese herbal medicine | |
| CN104587175B (en) | A kind of Chinese medicine preparation for treating diabetes | |
| CN102120000B (en) | Composition of effective parts of traditional Chinese medicine preparation for resisting Coxsackie virus B and preparation method thereof | |
| CN108904673A (en) | It is a kind of for treating the Chinese medicine combination of diabetes and surrounding lesion | |
| CN101642477A (en) | Application of traditional Chinese medicine of pteris multifida | |
| CN105148240A (en) | Medicinal preparation used for treating chronic cardiac failure | |
| CN104888023A (en) | Traditional Chinese medicine preparation for decreasing blood sugar | |
| CN101199652A (en) | Medicament for treating acute, subacute eczema and preparing method thereof | |
| CN109363182A (en) | A kind of food and medicament dual-purpose composition of postpartum enriching yin qi-restoratives and preparation method thereof | |
| CN104436022A (en) | Hemsleya-macrosperma-containing traditional Chinese medicine composition for treating diabetes mellitus | |
| CN106860758A (en) | Reduce Chinese medicine composition and its application of blood sugar | |
| CN109771631B (en) | Agastache rugosus, ginger and jujube composition and preparation method thereof | |
| CN106236810A (en) | A kind of extracting method of Folium Artemisiae Argyi effective ingredient | |
| CN105106356A (en) | Preparation method for blood lipid reducing and calming tablets |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181218 Address after: 409800 Building A, Phase 2, Banxi Light Industrial Park, Youyang County, Chongqing Patentee after: Chongqing Wanyuan Pharmaceutical Co., Ltd. Address before: No. 34 Nanshan Road, Nanshan Street, Nanan District, Chongqing 400065 Patentee before: Chongqing Academy of Chinese Materia Medica |
|
| TR01 | Transfer of patent right |